Target intelligence / Profile preview

Streptococcus pneumoniae virulence factors

Molecular classification
Bacterial antigen, Polysaccharide, Microbial protein, Toxin
01

Overview

Streptococcus pneumoniae virulence factors are a diverse array of molecules that enable the bacterium to colonize the host, evade immune detection, and cause systemic disease. The most critical factor is the polysaccharide capsule, which inhibits opsonophagocytosis and defines the various serotypes of the species (Kadioglu et al., 2008). Other significant factors include pneumolysin, a potent toxin that creates pores in host cell membranes, and surface proteins like PspA and PspC that assist in mucosal attachment and complement inhibition (Mitchell & Mitchell, 2010). Unlike traditional drug targets that are inhibited by small molecules, these factors serve as antigens in pneumococcal vaccines such as PCV13 and PPSV23 (CDC, 2023). Vaccination introduces these antigens to the host immune system to stimulate the production of protective antibodies and memory cells. These antibodies subsequently recognize the virulence factors on invading bacteria, facilitating their clearance through the immune system's natural mechanisms such as opsonization and complement-mediated lysis (Paton, 1996).

Other names
Pneumococcal antigensCapsular polysaccharidesPneumolysinPneumococcal surface protein APneumococcal surface protein C
02

Mechanism of action

Vaccines containing these virulence factors act as antigens to stimulate the production of specific antibodies (IgG) and memory B cells. These antibodies then recognize the virulence factors on live bacteria, leading to opsonization, complement activation, and phagocytosis (CDC, 2023).

03

Biological functions

Bacterial pathogenesisImmune evasionCell adhesionCytolysis
04

Disease associations

PneumoniaMeningitisBacteremiaOtitis mediaInfection
05

Safety considerations

Serotype replacementInjection site reactionsHypersensitivityFever
06

Interacting drugs

Pneumococcal 13-valent conjugate vaccine (PCV13)

3 more in the full profile.

07

Biomarkers

Serotype-specific IgG concentrationOpsonophagocytic activity (OPA) titers

Beyond the preview

Go deeper on Streptococcus pneumoniae virulence factors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcus pneumoniae virulence factors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call